Cure My Disease

Don't miss your cure!

Home News Browse About
Log in / Sign up
← Back to home

DOUBLE BLIND

Clinical trials for DOUBLE BLIND explained in plain language.

Never miss a new study

Get alerted when new DOUBLE BLIND trials appear

Sign up with your email to follow new studies for DOUBLE BLIND, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1
Sort by
  • New immunotherapy combo aims to improve First-Line lung cancer treatment

    Disease control Recruiting now

    This study tests whether a new drug called SCTB41, when combined with chemotherapy, works better than the standard immunotherapy tislelizumab plus chemotherapy for people with advanced non-small cell lung cancer that has no targetable genetic mutations. The trial has two parts: a…

    Matched conditions: DOUBLE BLIND

    Phase: PHASE2, PHASE3 • Sponsor: Sinocelltech Ltd. • Aim: Disease control

    Last updated Jun 27, 2026 14:02 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse About Terms of use Contact us

This is a site from Cyber and Space